在撒哈拉以南非洲农村地区使用单片三重抗高血压疗法:初步经验
Clara Stroppa1,2, Isabella Hunjan1,2, Alice Umulisa3
1School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Cardiology and therapy
|February 12, 2024
概括
单片,低剂量联合治疗高血压是有效的,可行的在撒哈拉以南非洲的农村地区. 这种方法可以在资源有限的环境中改善血压控制.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 农村医学 农村医学
背景情况:
- 动脉高血压是全球领先的可修改心血管风险因素.
- 国际指导方针提倡单片,低剂量组合作为初始高血压治疗.
- 该战略在撒哈拉以南非洲农村地区的可行性尚未被探索.
研究的目的:
- 在撒哈拉以南非洲农村人口中评估每天服用一次单片药物治疗高血压的可行性和有效性.
- 在这个特定的人群中评估血压控制和治疗坚持.
主要方法:
- 通过标准化血压测量来诊断高血压.
- 98名参与者每天接受一次的奥尔梅沙坦,阿姆洛迪平和甲酸的单片组合.
- 在16周内,对治疗的坚持,调整和副作用进行了监测.
主要成果:
- 79名参与者 (81%) 坚持治疗方案.
- 94%的参与者在第16周实现了血压目标 (<140/90 mmHg).
- 该疗法在患者中表现出极好的耐受性.
结论:
- 在撒哈拉以南非洲农村地区,初步治疗高血压每天服用一次单片药物组合是可行的和有效的.
- 这一战略为低收入和中等收入国家提供了可靠的第一线治疗选择.
- 建议在偏远地区增加单药组合的可用性.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
629
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
629
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
640
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
640
Antihypertensive Drugs: Angiotensin II Receptor Blockers
731
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
731
Antihypertensive Drugs: Types of β-Blockers
680
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
680
Antihypertensive Drugs: Action of β1 Blockers
447
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
447


